MSD receives FDA approval for Enflonsia to prevent RSV
Pharmaceutical Technology
JUNE 10, 2025
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. “We Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
Let's personalize your content